Non-muscle Invasive Bladder Cancer
📧 Sign up to get email alerts when something new happens for Non-muscle Invasive Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients [Phase 3]
A Phase 3 trial is evaluating the efficacy and safety of neoadjuvant intravesical Mitomycin C in high-risk non-muscle-invasive bladder cance…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC [Phase 1, Phase 2]
This is a clinical trial update for SHR-1501 alone or in combination with BCG or SHR-1316 in high-risk non-muscle invasive bladder cancer (N…
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC [Phase 1]
A Phase 1 trial evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of SIM0237 alone or in combination with BCG …
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer [Phase 1, Phase 2]
A clinical trial update on BH011 evaluating safety, tolerability, and preliminary efficacy in non-muscle-invasive bladder cancer across Phas…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial) [NA]
A clinical trial from University of Virginia is investigating pre-habilitation with mindfulness and exercise for bladder cancer patients und…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients [Phase 3]
Phase 3 trial evaluating atezolizumab plus one-year BCG instillations in BCG-naive high-risk non-muscle invasive bladder cancer patients; th…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr [Phase 1, Phase 2]
A phase 1/2 clinical trial at University College London is evaluating durvalumab in combination with the S-488210/S-488211 vaccine for non-m…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC) [Phase 1]
A Phase I clinical trial update announcing recruitment for SHR-2005 intravesical instillation in patients with intermediate- and high-risk n…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Can Second Resection for pT1 Bladder Cancer be Avoided After Initial En-Bloc Resection With Negative Safety Margins
A Mansoura University trial is assessing whether a second transurethral resection for pT1 bladder cancer can be avoided after an initial en-…
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: A Clinical Trial Evaluating the Efficacy and Safety of Disitamab Vedotin Plus Tislelizumab Combined with Re-TURBT in the Treatment of HER-2-high Expression(2+-3+) Non-muscle Invasive Bladder Cancer At High-risk and Very High-risk. [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of Disitamab Vedotin plus tislelizumab with re-TURBT in patients with HER-2-h…
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: A Clinical Trial Aimed at Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer [Phase 1]
A Phase 1 clinical trial update describing a study of VT-101 for Non-muscle Invasive Bladder Cancer, currently recruiting to assess safety a…
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC) [Phase 1]
A Phase 1 clinical trial update indicating that 9MW2821 is being evaluated for safety and efficacy in high-risk non-muscle-invasive bladder …
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating OH2 oncolytic viral therapy for non-muscle-invasive bladder cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: The Impact of PDD During TURB for NMIBC [Phase 4]
Phase 4 trial update evaluating photodynamic diagnosis during transurethral resection of bladder tumor for non-muscle invasive bladder cance…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer [Phase 2]
This document reports a Phase 2 clinical trial evaluating radiotherapy for BCG-unresponsive non-muscle-invasive bladder cancer in situ (CIS)…
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment [Phase 1, Phase 2]
Clinical trial update evaluating camrelizumab for high-risk non-muscle-invasive bladder cancer that failed BCG treatment, spanning Phase 1 a…
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer [Phase 2]
Disitamab Vedotin is being studied in combination with Bacillus Calmette-Guérin (BCG) therapy for HER2-expressing high-risk non-muscle invas…
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2 [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating intravesical Disitamab Vedotin (RC48) for high-risk non-muscle invasive bladder cancer expressing H…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer [Phase 3]
Phase 3 study evaluating adding mitomycin C to Bacillus Calmette-Guérin for high-risk non-muscle-invasive bladder cancer; the trial is curre…
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients [Phase 1]
Phase 1 clinical trial update on intravesical instillation of T3011 for non-muscle-invasive bladder cancer. Sponsored by Fudan University, t…
-
CLINICAL_TRIALS research · 2018-07-24Clinical Trial Update: The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study [NA]
A prospective randomized Phase II trial evaluating whether anesthetic method during transurethral resection of bladder mass affects two-year…
-
CLINICAL_TRIALS research · 2017-07-21Clinical Trial Update: "En Bloc" Resection of NMIBC: a Prospective， Single Centre，Randomized Study [Phase 4]
A Phase 4, prospective, single-centre randomized study evaluating en bloc resection for non-muscle invasive bladder cancer (NMIBC) at Tongji…
-
CLINICAL_TRIALS research · 2017-05-23Clinical Trial Update: Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC [NA]
This clinical trial update compares the Storz Professional Image Enhancement System with white-light imaging for transurethral resection of …
-
CLINICAL_TRIALS research · 2017-05-23Clinical Trial Update: Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects? [Phase 4]
A Phase 4 clinical trial compares solifenacin, levofloxacin, and lornoxicam for managing side effects of intravesical BCG therapy in non-mus…
-
CLINICAL_TRIALS research · 2017-05-16Clinical Trial Update: A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
The document announces an update on a prognostic model intended to predict outcomes for patients with non-muscle invasive bladder cancer.